☆ 4.4 Review

Understanding immunity to influenza: implications for future vaccine development

EXPERT REVIEW OF VACCINES (2023)

Related references

Note: Only part of the references are listed.

Article Biotechnology & Applied Microbiology

Rise of the RNA machines – self-amplification in mRNA vaccine design

Jerome D.G. Comes et al.

TRENDS IN BIOTECHNOLOGY (2023)

Add to Collection

Article Virology

Development of a Multi-Epitope Universal mRNA Vaccine Candidate for Monkeypox, Smallpox, and Vaccinia Viruses: Design and In Silico Analyses

Nino Rcheulishvili et al.

Summary: Despite the availability of a smallpox vaccine effective against monkeypox, there is a strong need to develop a universal vaccine candidate against monkeypox virus due to the increasing global concern caused by the multi-country outbreak.

VIRUSES-BASEL (2023)

Add to Collection

Article Immunology

New-age vaccine adjuvants, their development, and future perspective

Shailendra Kumar Verma et al.

Frontiers in Immunology (2023)

Add to Collection

Review Immunology

Immune interference in effectiveness of influenza and COVID-19 vaccination

Yiwen Xie et al.

Summary: Vaccines have been successful in controlling infectious diseases, but influenza and COVID-19 vaccines face challenges due to the variability of the viral proteins. Immune imprinting and repeated vaccinations can negatively influence vaccine effectiveness, and co-administration of multiple vaccines can also interfere with their effectiveness. Future development of COVID-19 vaccines should focus on inducing cross-reactive T-cell responses and naive B-cell responses, while the strategy of co-administering influenza and COVID-19 vaccines needs more careful consideration and further clinical data.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Review Immunology

Immune Imprinting and Implications for COVID-19

Zhiqian Zhou et al.

Summary: Immunological memory plays a crucial role in protective immunity against pathogens. In the current COVID-19 pandemic, the combination of exposure to viral antigens from infection and/or vaccination shapes a distinct immunological memory. However, immune imprinting may limit the generation of a new immune response against variant infections or response to future vaccines. This review focuses on B cell immunobiology to understand the mechanistic basis of immune imprinting and discusses its harmful effects and impact on SARS-CoV-2 infection and vaccination.

VACCINES (2023)

Add to Collection

Article Medicine, General & Internal

Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods

Ruth Link-Gelles et al.

Summary: This study found that the SARS-CoV-2 Omicron sublineages BA.4 and BA.5 may have greater immune evasion and provide less protection against COVID-19 after vaccination. The research evaluated the vaccine effectiveness of 2, 3, or 4 doses of COVID-19 mRNA vaccination during the BA.4 or BA.5 predominant period, and assessed the severity of COVID-19 in hospitalized patients across different Omicron sublineage periods.

JAMA NETWORK OPEN (2023)

Add to Collection

Article Virology

Contribution of Neuraminidase to the Efficacy of Seasonal Split Influenza Vaccines in the Ferret Model

Miruna E. Rosu et al.

Summary: This study demonstrates the importance of matching the neuraminidase (NA) component in influenza vaccines to prevent severe disease and reduce virus replication and shedding. It highlights the need to consider NA during vaccine strain selection, especially when the hemagglutinin (HA) component is mismatched.

JOURNAL OF VIROLOGY (2022)

Add to Collection

Article Biotechnology & Applied Microbiology

The beginning and ending of a respiratory viral pandemic-lessons from the Spanish flu

Harald Brussow

Summary: As the COVID-19 pandemic enters its third year, studying historical viral respiratory pandemics can provide insight into the dynamics of pandemics.

MICROBIAL BIOTECHNOLOGY (2022)

Add to Collection

Review Pharmacology & Pharmacy

Sustained delivery approaches to improving adaptive immune responses

Ben S. Ou et al.

Summary: The immune system plays a crucial role in regulating and protecting human health. Sustained release technologies have shown potential in enhancing adaptive immune responses by prolonging exposure to immunogenic signals.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Add to Collection

Editorial Material Multidisciplinary Sciences

mRNA, the beginning of a new influenza vaccine game

Simone Pecetta et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Article Multidisciplinary Sciences

A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes

Claudia P. Arevalo et al.

Summary: It is important to develop a vaccine that can provide cross-reactive and subtype-specific antibodies as seasonal influenza vaccines offer limited protection against pandemic influenza virus strains. This study developed a multivalent vaccine using nucleoside-modified mRNA encoding hemagglutinin antigens from all known influenza virus subtypes, which elicited high levels of antibodies in mice and ferrets that reacted to multiple antigens. Vaccination with this mRNA vaccine protected mice and ferrets from both matched and mismatched viral strains.

SCIENCE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Self-amplifying RNA vaccines for infectious diseases

Kristie Bloom et al.

Summary: Vaccinology is moving towards synthetic RNA platforms, which offer rapid, scalable, and cell-free manufacturing of prophylactic and therapeutic vaccines. Self-amplifying RNAs have shown enhanced antigen expression at lower doses compared to conventional mRNA, potentially improving immunity and becoming important vaccine candidates.

GENE THERAPY (2021)

Add to Collection

Review Infectious Diseases

Assessment of the benefits of seasonal influenza vaccination: Elements of a framework to interpret estimates of vaccine effectiveness estimates and support robust decision-making and communication

Rosalind Hollingsworth et al.

Summary: Systematic reviews and meta-analyses confirm that influenza vaccination can reduce the risk of influenza illness by 40% to 60% when well matched to circulating strains. However, the effectiveness of influenza vaccine is often conflicting and confusing for decision makers. Understanding the limitations and complexities of IVE studies is crucial for accurate interpretation and informed decision-making.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2021)

Add to Collection

Editorial Material Immunology

Antigenic drift: Understanding COVID-19

Jonathan W. Yewdell

IMMUNITY (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

A changing trend in diagnostic methods of Influenza A (H3N2) virus in human: a review

Ravina et al.

Summary: The influenza virus is classified into four types, with type A and B responsible for major illnesses in humans, particularly influenza pandemic caused by type A. Within type A, the H1N1 and H3N2 subtypes have caused numerous flu pandemics, with H3N2 evolving rapidly and H1N1 showing smaller changes. Detection methods for influenza A(H3N2) viruses include conventional serological methods, molecular biology techniques, and biosensors, all aimed at improving specificity and sensitivity for rapid and accurate detection.

3 BIOTECH (2021)

Add to Collection

Article Immunology

Influenza Vaccines: Successes and Continuing Challenges

Tanja Becker et al.

Summary: Influenza vaccines have been available for over 80 years and have contributed significantly to reducing morbidity and mortality. However, limitations in their effectiveness persist due to antigenic evolution and production methods. Alternative approaches are being pursued to design and produce vaccines with broader and longer-lasting immune responses.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Medicine, General & Internal

SARS-CoV-2 Vaccines

C. Buddy Creech et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Review Immunology

Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game

Jean-Louis Palgen et al.

Summary: Optimizing vaccination strategies involves understanding how vaccine history affects memory B and T cell characteristics. Innate cells, particularly myeloid lineage cells, respond differently to first and second vaccine doses, affecting innate immune responses. Trained innate cells have the potential to improve vaccination strategies by enhancing antigen uptake, presentation, migration, and cytokine production.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Microbiology

Reassortment Network of Influenza A Virus

Xingfei Gong et al.

Summary: By assembling and analyzing whole-genome sequences of IAVs, researchers systematically identified 1,927 possible reassortment events and constructed a reassortment network, revealing the intermediate host role of swine in the reassortment history of IAVs. Furthermore, reassortment patterns among related subtypes constructed in this study are consistent with previous research.

FRONTIERS IN MICROBIOLOGY (2021)

Add to Collection

Review Immunology

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target

Sarah Creytens et al.

Summary: Neuraminidase of influenza viruses is crucial in the virus life cycle and a key target of the host immune system. Recent research has focused on utilizing neuraminidase to enhance the protective potential of influenza vaccines. Understanding the antigenicity and immune responses of neuraminidase can provide valuable insights for vaccine design and flu control strategies.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Emerging concepts in the science of vaccine adjuvants

Bali Pulendran et al.

Summary: Adjuvants are vaccine components that enhance the immune response. Recent advances in understanding the molecular mechanisms and systems vaccinology have revitalized the science and development of novel adjuvants for use in vaccines against COVID-19 and future pandemics.

NATURE REVIEWS DRUG DISCOVERY (2021)

Add to Collection

Review Infectious Diseases

Immune-mediated attenuation of influenza illness after infection: opportunities and challenges

Manish M. Patel et al.

Summary: The ultimate goal of influenza vaccines is to achieve sterilising immunity, preventing illness and reinfection. Immunity attenuation may reduce severity of disease but can lead to reinfections with homologous viruses.

LANCET MICROBE (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of mRNA Covid-19 Vaccine among US Health Care Personnel

T. Pilishvili et al.

Summary: The BNT162b2 and mRNA-1273 vaccines were highly effective in preventing symptomatic Covid-19 in U.S. health care personnel, with vaccine effectiveness of 77.6% to 96.3%. The effectiveness was consistent across different subgroups defined by age, race and ethnic group, underlying conditions, and patient contact levels, indicating the vaccines were effective for preventing Covid-19 in those at risk and in disproportionately affected groups.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Immunology

Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships

Louise C. Druedahl et al.

Summary: Collaboration is crucial in the fight against COVID-19, especially in the rapid development of safe and effective vaccines. Partnerships have become a significant means for vaccine development during the pandemic, with nearly one third of vaccine candidates being developed through partnerships using next-gen vaccine platforms. These partnerships vary between materials-transfer partnerships and knowledge sharing partnerships, shaping the collaboration and impacting knowledge and technology development in the field.

VACCINE (2021)

Add to Collection

Article Immunology

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

Sonia Budroni et al.

Summary: Differences in innate immune 'imprinting' between vaccine adjuvants may mediate dissimilar effects on the quantity and quality of persisting adaptive responses. Specific combinations of immunoenhancers in the adjuvant systems increase antibody persistence and avidity maturation. Different adjuvants have varied effects on the duration and maturity of adaptive immune responses.

NPJ VACCINES (2021)

Add to Collection

Review Immunology

An Overview of Influenza Viruses and Vaccines

Rina Fajri Nuwarda et al.

Summary: Influenza is a major public health concern, and vaccines are an effective method for prevention and control. New vaccine platforms and advancements in vaccine manufacturing processes are being explored to improve effectiveness and stability.

VACCINES (2021)

Add to Collection

Review Immunology

A guide to vaccinology: from basic principles to new developments

Andrew J. Pollard et al.

Summary: Immunization is vital for public health policy and there are challenges ahead for immunologists in developing new vaccines. Although immunology has not contributed significantly to vaccine development so far, a better understanding of protective immunity is urgently needed to tackle difficult-to-target pathogens.

NATURE REVIEWS IMMUNOLOGY (2021)

Add to Collection

Editorial Material Immunology

Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?

Steven Rockman et al.

VACCINES (2020)

Add to Collection

Review Immunology

Modulation of immune responses using adjuvants to facilitate therapeutic vaccination

Virgil Schijns et al.

IMMUNOLOGICAL REVIEWS (2020)

Add to Collection

Article Immunology

Designing Multi-Epitope Vaccines to Combat Emerging Coronavirus Disease 2019 (COVID-19) by Employing Immuno-Informatics Approach

Anam Naz et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Review Immunology

Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine

Luca T. Giurgea et al.

VACCINES (2020)

Add to Collection

Article Microbiology

Persistent Antibody Clonotypes Dominate the Serum Response to Influenza over Multiple Years and Repeated Vaccinations

Jiwon Lee et al.

CELL HOST & MICROBE (2019)

Add to Collection

Review Microbiology

Factors That Influence the Immune Response to Vaccination

Petra Zimmermann et al.

CLINICAL MICROBIOLOGY REVIEWS (2019)

Add to Collection

Review Virology

Targeting Hemagglutinin: Approaches for Broad Protection against the Influenza A Virus

Yun Zhang et al.

VIRUSES-BASEL (2019)

Add to Collection

Review Immunology

The Future of Flu: A Review of the Human Challenge Model and Systems Biology for Advancement of Influenza Vaccinology

Amy Caryn Sherman et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Add to Collection

Article Immunology

Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus

Sean A. Nelson et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Editorial Material Infectious Diseases

Influenza imprinting in childhood and the influence on vaccine response later in life

Alyson A. Kelvin et al.

EUROSURVEILLANCE (2019)

Add to Collection

Article Biotechnology & Applied Microbiology

Different Subtypes of Influenza Viruses Target Different Human Proteins and Pathways Leading to Different Pathogenic Phenotypes

Yujie Wang et al.

BIOMED RESEARCH INTERNATIONAL (2019)

Add to Collection

Review Immunology

The human antibody response to influenza A virus infection and vaccination

Florian Krammer

NATURE REVIEWS IMMUNOLOGY (2019)

Add to Collection

Review Immunology

Advances in mRNA Vaccines for Infectious Diseases

Cuiling Zhang et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Cell Biology

Is It Possible to Develop a Universal Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine

Florian Krammer et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)

Add to Collection

Article Engineering, Biomedical

Designing immunostimulatory double stranded messenger RNA with maintained translational activity through hybridization with poly A sequences for effective vaccination

Satoshi Uchida et al.

BIOMATERIALS (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Structural insights into the design of novel anti-influenza therapies

Nicholas C. Wu et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

Add to Collection

Review Microbiology

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

Florian Krammer et al.

MBIO (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Structural insights into the design of novel anti-influenza therapies

Nicholas C. Wu et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

Add to Collection

Review Biotechnology & Applied Microbiology

Immune responses after live attenuated influenza vaccination

Kristin G. -I. Mohn et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

Add to Collection

Review Immunology

Immune History and Influenza Vaccine Effectiveness

Joseph A. Lewnard et al.

VACCINES (2018)

Add to Collection

Review Medicine, Research & Experimental

Latest development on RNA-based drugs and vaccines

Kenneth Lundstrom

FUTURE SCIENCE OA (2018)

Add to Collection

Article Multidisciplinary Sciences

A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants

Wilfred Ndifon

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2015)

Add to Collection

Article Immunology

Live Attenuated and Inactivated Influenza Vaccines in Children

Natalia A. Ilyushina et al.

JOURNAL OF INFECTIOUS DISEASES (2015)

Add to Collection

Review Immunology

Innate immunity to influenza virus infection

Akiko Iwasaki et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Add to Collection

Review Microbiology

Traditional and New Influenza Vaccines

Sook-San Wong et al.

CLINICAL MICROBIOLOGY REVIEWS (2013)

Add to Collection

Article Immunology

Protective CD8 T Cell-Mediated Immunity against Influenza A Virus Infection following Influenza Virus-like Particle Vaccination

Emily A. Hemann et al.

JOURNAL OF IMMUNOLOGY (2013)

Add to Collection

Article Microbiology

New World Bats Harbor Diverse Influenza A Viruses

Suxiang Tong et al.

PLOS PATHOGENS (2013)

Add to Collection

Review Immunology

Mechanisms of action of adjuvants

Sunita Awate et al.

FRONTIERS IN IMMUNOLOGY (2013)

Add to Collection

Article Biochemistry & Molecular Biology

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Tom M. Wilkinson et al.

NATURE MEDICINE (2012)

Add to Collection

Article Infectious Diseases

Fundamentals of Vaccine Immunology

Angela S. Clem

JOURNAL OF GLOBAL INFECTIOUS DISEASES (2011)

Add to Collection

Review Immunology

Vaccine Adjuvants: Putting Innate Immunity to Work

Robert L. Coffman et al.

IMMUNITY (2010)

Add to Collection

Article Multidisciplinary Sciences

Mapping the antigenic and genetic evolution of influenza virus

DJ Smith et al.

SCIENCE (2004)

Add to Collection

Article Immunology

Improving vaccine performance with adjuvants

FR Vogel

CLINICAL INFECTIOUS DISEASES (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.